ArticleACS pharmacology & translational science2025
Comprehensive Analysis of Clinically Discontinued Compounds Using an In Vitro Secondary Pharmacology Panel to Predict Potential Safety Risks during Drug Development.
Verena Albert et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.